Pexelizumab Alexion 2002 (English)In: Current Opinion in Investigational Drugs, ISSN 1472-4472, Vol. 3, no 6, p. 870-877Article in journal (Refereed) Published

Place, publisher, year, edition, pages

2002. Vol. 3, no 6, p. 870-877

Keywords [en]

Animals, Antibodies; Monoclonal/administration & dosage/*therapeutic use, Cardiopulmonary Bypass, Cardiovascular Diseases/surgery, Clinical Trials; Phase I, Clinical Trials; Phase II, Clinical Trials; Phase III, Complement Activation/immunology, Complement C5/*antagonists & inhibitors/immunology, Coronary Artery Bypass, Humans, Myocardial Reperfusion Injury/immunology/*prevention & control, Postoperative Complications/immunology/*prevention & control, Randomized Controlled Trials, Treatment Outcome

Identifiers

URN: urn:nbn:se:hj:diva-6051PubMedID: 12137406OAI: oai:DiVA.org:hj-6051DiVA, id: diva2:36871

Available from: 2008-07-08 Created: 2008-07-08Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

PubMedhttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Retrieve&list_uids=12137406&dopt=Citation

By organisation

HHJ, Dep. of Natural Science and Biomedicine

Search outside of DiVA

GoogleGoogle ScholarTotal: 120 hits